Supportive Drugs in Leukemia Treatment During Pregnancy

The diagnosis of leukemia during pregnancy is a rare event. The low incidence of leukemia that occurs during pregnancy generates few reports of management, which makes it difficult to search for updated information. Considering that strategies for chemotherapy treatment of leukemia in this population are the same as those used for non-pregnant patients, it is necessary to make an adequate assessment if the chosen medication can bring more risks than benefits during pregnancy, for both the mother and the fetus. Supportive drugs are used to manage adverse events that must be well stabilized, as some of them may be contraindicated or inadvisable during pregnancy. This chapter aims to gather information from the literature on the main drugs involved in the supportive therapy of symptoms presented during chemotherapy treatment of leukemia in pregnancy, as well as safety and risk data in the stages of pregnancy.